Costanzo A., Llamas-Velasco M., Fabbrocini G., Cuccia A., Rivera-Diaz R., Du Jardin, KG, Kasujee I., Puig L., Carrascosa J.M.. Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate-to-severe plaque psoriasis patients in conditions close to clinical practice. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(10)DOI:10.1111/jdv.19229. PMID:37246505. IF:8.500(Q1/1D).

Zabotti, A, De Marco, G, Gosset, L, Baraliakos, X, Aletaha, D, Iagnocco, A, Gisondi, P, Balint, PV, Bertheussen, H, Boehncke, WH, Damjanov, NS, de Wit, M, Errichetti, E, Marzo-Ortega, H, Protopopov, M, Puig, L, Queiro, R, Ruscitti, P, Savage, L, Schett, G, Siebert, S, Stamm, TA, Studenic, P, Tinazzi, I, Van den Bosch, FE, van der Helm-van Mil, A, Watad, A, Smolen, JS, McGonagle, DG. EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis. ANNALS OF THE RHEUMATIC DISEASES. 2023; 82(9)DOI:10.1136/ard-2023-224148. PMID:37295926. IF:20.300(Q1/1D).

Sanchez-Rodriguez, G, Puig, L. Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(12)DOI:10.3390/ijms241210305. PMID:37373452. IF:4.900(Q1/3D).

Ruiz-Salas, V, Podlipnik, S, Sandoval-Clavijo, A, Sanmartin-Jimenez, O, Bernia-Petit, E, Bonfill-Orti, M, Bassas-Freixas, P, Yebenes-Marsal, M, Florez-Menendez, A, Sola-Ortigosa, J, Just-Sarobe, M, Aguayo-Ortiz, RS, Niubo, EMI, Quintana-Codina, M, Deza, G, Jaka, A, Fuentes, MJ, Canueto, J, Toll, A. Real-world experience with vismodegib on advanced and multiple BCCs: data from the RELIVIS study. DERMATOLOGY. 2023; 239(5)DOI:10.1159/000530813. PMID:37257423. IF:3.000(Q2/4D).